-
Vitamin C, ROS/NF-κB, and Cochlear Senescence
2026-09-28
A 2024 Molecular Biology Reports study used D-galactose-treated HEI-OC1 cochlear hair cells to examine whether vitamin C can counter cellular senescence through the ROS/NF-κB axis. By including N-acetyl-L-cysteine as a redox-oriented comparator, the work connects reduced oxidative burden with improved viability, lower senescence markers, and less inflammatory signaling, while remaining an in vitro mechanistic study.
-
Primidone in ALS: From RIPK1 to Biomarkers
2026-09-28
Primidone (Mysoline) is being investigated in ALS not only as a drug candidate, but also as a probe of RIPK1-related biology. This article examines what the clinical biomarker findings support, what they do not establish, and how to design more informative follow-up assays.
-
Npt1-Mediated Renal Transport of Faropenem
2026-09-27
A 2000 Xenopus oocyte study identified mouse Npt1 as a transporter of faropenem and provided evidence that it may support the luminal step of renal secretion. The findings connect a phosphate transporter to penem antibiotic disposition, while leaving the transporter’s quantitative contribution in intact kidneys and humans unresolved.
-
Protease Inhibitor Cocktail for Lysosome Research
2026-09-26
Preserve TECPR1, KIF1A, and other protein targets during lysosome-damage studies without introducing EDTA into cation-sensitive workflows. This practical guide shows how to use a 100X inhibitor stock during extraction, choose downstream assays, and troubleshoot common losses in signal or complex recovery.
-
Protease Inhibitor Cocktail for HepaRG Workflows
2026-09-25
Fast-differentiated HepaRG cells can make hepatitis D virus experiments more accessible, but protein readouts still depend on careful sample handling. Learn where an EDTA-free Protease Inhibitor Cocktail fits—from cold lysis for immunoblotting to cation-sensitive assays—and where its role ends.
-
APOL1 Evolution, Isoforms, and APOL3 Interactions
2026-09-25
Khalaila and Skorecki integrate APOL1 haplotype analysis, splice-isoform biology, and APOL3 interaction findings to frame new routes for investigating variant-associated cellular injury. Their work strengthens the case for studying APOL1 variants in their genetic and isoform contexts, while leaving the mechanism of kidney injury an open question.
-
Protease Inhibitor Cocktail EDTA-Free: K1010
2026-09-24
Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) helps limit endogenous proteolysis during protein extraction and sample preparation. Use it in workflows that need protease control while retaining divalent cations; it is not a substitute for phosphatase inhibitors or a complete assay buffer.
-
Lipo3K Transfection Reagent for Resistance Research
2026-09-24
Use Lipo3K Transfection Reagent to test how candidate genes contribute to paclitaxel resistance, from single-gene knockdown to DNA and siRNA co-transfection. A practical workflow connects the reference study’s cholesterol–transporter findings to tractable cell-based experiments, while separating proposed assay design from the paper’s reported results.
-
Bifendate (DDB): Reliable Assay Design
2026-09-23
A practical, evidence-led guide to using Bifendate (DDB), SKU BA1823, in cell viability, cytotoxicity, autophagy, and lipid-metabolism studies. It covers solvent compatibility, starting exposure conditions, interpretation limits, and how to assess supplier options without overstating the evidence.
-
AEBSF.HCl in Protease and Necroptosis Assays
2026-09-23
AEBSF.HCl is an irreversible serine protease probe for stabilizing lysates, testing APP processing, and dissecting protease-dependent cell lysis. Used alongside—not instead of—cathepsin-focused tools, it can clarify whether a phenotype reflects serine protease activity or lysosomal membrane permeabilization.
-
Adipocyte-Targeted CRISPRi for Obesity and Insulin Resistanc
2026-09-22
The reference study combines Fabp4-directed CRISPR interference with an adipose-targeting peptide to repress gene expression selectively in mature white adipocytes. In obese mice, this nonviral strategy reduced body weight and inflammation while improving hepatic steatosis and insulin resistance, providing a proof of concept for tissue-directed metabolic gene regulation.
-
CENPI, Wnt/β-Catenin, and Breast Cancer Progression
2026-09-22
Wu and colleagues identify centromere protein I (CENPI) as an overexpressed driver of breast cancer progression and connect its activity to Wnt/β-catenin signaling. By combining clinical datasets, cellular and xenograft models, RNA sequencing, and pathway reporter assays, the study provides a mechanistic framework for evaluating CENPI as a biomarker and therapeutic target.
-
AMG 9810 Workflows for TRPV1 Research
2026-09-21
AMG 9810 provides a reversible, selective way to separate TRPV1-driven calcium and CGRP responses from broader sensory-cell stress signals. This workflow combines concentration-controlled antagonism, paired functional readouts, and metabolic-stress controls for more rigorous pain mechanism research and sensory neuron signaling studies.
-
Two-Component BoNT-Like Toxins in P. ghonii
2026-09-21
Lee and colleagues identified PG1 and PG2, unusual two-component botulinum neurotoxin–like proteins from Paeniclostridium ghonii that selectively cleave insect SNAP25. Structural, biochemical, and insect-injection experiments connect their architecture to host-specific toxicity and suggest a foundation for studying new bacterial biocontrol proteins.
-
EDTA-Free Protease Inhibitor Cocktail K4002
2026-09-20
The Protease Inhibitor Cocktail is an EDTA-Free Protease Inhibitor solution for broad-spectrum control of proteolysis during cell and tissue extraction. Its 100X formulation in DMSO targets serine, cysteine, acidic, aminopeptidase, and metalloprotease activities for protein-focused workflows.